Overview

Intradiscal rhGDF-5 Phase I/II Clinical Trial

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

Study to show the effectiveness and safety of a single injection of rhGDF5 into a degenerating single spinal disc in treating lumbar level degenerative disc disease

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

DePuy Spine